DS
JAGX icon

DRW Securities’s Jaguar Health JAGX Stock Holding History

DRW Securities’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37
Closed -$16.6K – 1525
2025
Q4 		$16.6K Sell
37
-154
-81% -$119K ﹤0.01% 1172
2025
Q3 		$212K Buy
+191
New +$194K ﹤0.01% 1047

Other funds holding JAGX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DRW Securities's JAGX Position: Q1 2026 in Review

DRW Securities sold out of Jaguar Health (JAGX) in Q1 2026, closing a stake of 37 shares — an estimated $16.6K sold.

DRW Securities first reported a position in JAGX in Q3 2025 and held it in 2 quarters. The position peaked at $212K in Q3 2025. 7 funds tracked by Wall St. Rank hold JAGX as of Q1 2026.

  • DRW Securities reported no remaining Jaguar Health position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 37 Jaguar Health shares in Q1 2026, an estimated $16.6K.
  • DRW Securities first reported a position in Jaguar Health in Q3 2025 and held it in 2 quarters.
  • DRW Securities's Jaguar Health position peaked at $212K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.